Literature DB >> 11129345

Characterization of the gammac chain among 27 unrelated Japanese patients with X-linked severe combined immunodeficiency (X-SCID).

S Kumaki1, N Ishii, M Minegishi, Y Ohashi, I Hakozaki, S Nonoyama, K Imai, T Morio, I Tsuge, Y Sakiyama, A Miyanoshita, J Miura, M Mayumi, T Heike, K Katamura, H Takada, I Izumi, J Kamizono, S Hibi, H Sasaki, M Kimura, A Kikuta, Y Date, M Sako, H Tanaka, K Sano, K Sugamura, S Tsuchiya.   

Abstract

X-linked severe combined immunodeficiency (X-SCID) is a rare fatal disease that is caused by mutations in the gene encoding the gammac chain. In this study, 27 unrelated Japanese patients with X-SCID were examined in terms of their genetic mutations and surface expression of the gammac chain. Among 25 patients examined, excluding two patients with large deletions, 23 different mutations were identified in the IL2RG gene, including 10 novel mutations. One patient bearing an extracellular mutation and all three of the patients bearing intracellular mutations after exon 7 expressed the gammac chain on the cell surface. Overall, 84% of patients lacked surface expression of the gammac chain leading to a diagnosis of X-SCID.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11129345     DOI: 10.1007/s004390000381

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  2 in total

1.  Progressive B Cell Loss in Revertant X-SCID.

Authors:  Connie H Lin; Hye Sun Kuehn; Timothy J Thauland; Christine M Lee; Suk See De Ravin; Harry L Malech; Timothy J Keyes; Astraea Jager; Kara L Davis; Maria I Garcia-Lloret; Sergio D Rosenzweig; Manish J Butte
Journal:  J Clin Immunol       Date:  2020-07-17       Impact factor: 8.317

2.  X-linked severe combined immunodeficiency syndrome: the first Korean case with gamma c chain gene mutation and subsequent genetic counseling.

Authors:  Eun-Kyeong Jo; Satoru Kumaki; Du Wei; Shigeru Tsuchiya; Hirokazu Kanegane; Chang-Hwa Song; Ha Young Noh; Young Ok Kim; So Yeon Kim; Hae Yul Chung; Yoon Ha Kim; Hoon Kook
Journal:  J Korean Med Sci       Date:  2004-02       Impact factor: 2.153

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.